Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CFR | ALSN |
|---|---|---|
| Price | $153.83 | $115.75 |
| Change today | ▼ 0.78% | ▼ 1.88% |
| Market cap | $9.56B | $9.56B |
| Return, 3 months | -1.6% | +1.6% |
| Return, year to date | +24.1% | +19.1% |
| Return, 1 year | +23.7% | +38.0% |
| P/E (TTM) | 14.5 | 18.3 |
| P/B | 2.1 | 4.8 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 2.62% | 0.97% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 38 | 43 |
| 30-day volatility | 14.9% | 27.1% |
| Max drawdown, 1 year | -11.4% | -20.4% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
